IHH Healthcare sets stage for next phase of growth in India

image credit- freepik

IHH Healthcare, Asia’s largest and leading multinational healthcare provider, has announced plans to accelerate expansion, deepen operational efficiencies, and drive innovation across its India hospital network, following the successful closure of the open offer for Fortis Healthcare Limited and Fortis Malar Hospitals Limited. IHH’s shareholding in Fortis now stands at 31.17% and 62.73% in Malar.

India remains one of the key growth markets where IHH is scaling strategically to establish world-class hospitals and elevate care delivery for patients across the country.

Harnessing enhanced operational scale, clinical excellence, and geographical reach across a combined network of 35 hospitals and over 5,000 beds spanning 11 states, IHH is leveraging operational and financial synergies to fuel its goal of adding approximately 2,000 new beds in India by 2028.

IHH is recognised internationally for operating some of the world’s most trusted healthcare brands including Acibadem, Gleneagles, Fortis, Island, Mount Elizabeth, Pantai, Parkway and Prince Court. It is the world’s most diversified healthcare groups, with a presence in 10 countries including Malaysia, Singapore, Turkiye, India and Greater China.

In August this year, IHH refreshed its brand identity to reflect its ambition to be a global healthcare leader, shaping the future of care by driving meaningful innovation, strategic partnerships and powerful synergies across the healthcare ecosystem.